Clinical trial
A Phase IIb, Randomized, Double-Blind, Placebo Controlled Study for the Treatment of Active Celiac Disease With Larazotide Acetate (AT-1001)
NCT00620451 is registered in ClinicalTrials.gov with 9 Meters Biopharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIb, Randomized, Double-Blind, Placebo Controlled Study for the Treatment of Active Celiac Disease With Larazotide Acetate (AT-1001)
- Lead sponsor
- 9 Meters Biopharma, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- December 31, 2009
- Enrollment
- 105 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.